Skip to main content
VCbacked
Log inGet Started

Aer Therapeutics

Raleigh, United States

Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.

$5.0M raised
Feb 2025
Venture - Series Unknown
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

OrbiMedCanaan PartnersHatteras Venture Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aer Therapeutics

How much funding has Aer Therapeutics raised?
Aer Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
Who are Aer Therapeutics's investors?
Aer Therapeutics's investors include OrbiMed, Canaan Partners, Hatteras Venture Partners.
Where is Aer Therapeutics headquartered?
Aer Therapeutics is headquartered in Raleigh, United States.
What does Aer Therapeutics do?
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
What stage is Aer Therapeutics at?
Aer Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aer Therapeutics — Funding & Investors." VCBacked, February 5, 2025, https://www.vcbacked.co/company/aer-therapeutics. Accessed June 10, 2026.
APA
VCBacked. (2025). Aer Therapeutics — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/aer-therapeutics
Wikipedia (cite web)
{{cite web |title=Aer Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aer-therapeutics |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong